A carregar...
Alternative splicing expands the prognostic impact of KRAS in microsatellite stable primary colorectal cancer
KRAS mutation is a well‐known marker for poor response to targeted treatment and patient prognosis in microsatellite stable (MSS) colorectal cancer (CRC). However, variation in clinical outcomes among patients wild‐type for KRAS underlines that this is not a homogeneous population. Here, we evaluate...
Na minha lista:
| Publicado no: | Int J Cancer |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6587976/ https://ncbi.nlm.nih.gov/pubmed/30121958 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ijc.31809 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|